Norman Sussman - 21 Feb 2023 Form 4 Insider Report for DURECT CORP (DRRX)

Role
Chief Medical Officer
Signature
/s/ Norman Sussman
Issuer symbol
DRRX
Transactions as of
21 Feb 2023
Net transactions value
$0
Form type
4
Filing time
23 Feb 2023, 12:23:46 UTC
Previous filing
10 Jan 2022
Next filing
16 Oct 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DRRX Stock Option (right to buy) Award $0 +45,000 $0.000000 45,000 21 Feb 2023 Common Stock 45,000 $5.07 Direct F1
transaction DRRX Stock Option (right to buy) Award $0 +24,557 $0.000000 24,557 21 Feb 2023 Common Stock 24,557 $5.07 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will vest and become exercisable in installments of one-sixteenth (1/16) of the total number of shares at the end of each three month period following the grant date, subject to the Reporting Person providing continuous service to the Issuer through the applicable vesting date.
F2 The option is fully vested and immediately exercisable.